Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baijun Fang

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
British Journal of Haematology|April 30, 2020
Addition of low-dose decitabine to bortezomib and dexamethasone as second-line therapy in multiple myelomaNing Li, Lina Liu, Pu Xiang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 25, 2014
[Efficacy of adjusted BACOD regimen on the treatment of relapsed refractory diffuse large B cell lymphoma]Gege Gong, Jianwei Du, Lihua Dong, et al.
Annals of Palliative Medicine|January 12, 2022
Glutathione combined with mecobalamin in the treatment of chemotherapy-induced peripheral neuropathy in multiple myeloma: a retrospective clinical studyHao Huang, Min Zhao, Xiyang Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 24, 2019
Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinomaXiaojuan Shi, Xinfeng Chen, Baijun Fang, et al.
Blood Advances|December 12, 2025
Genome-wide copy number profiling enhances risk stratification in multiple myeloma by shallow whole-genome sequencingBaijun Fang, Zunmin Zhu, Yinyin Chang, et al.
Experimental Hematology|July 5, 2003
Hemangioblastic characteristics of fetal bone marrow-derived Flk1(+)CD31(-)CD34(-) cellsHong Guo, Baijun Fang, Lianming Liao, et al.
Blood Advances|February 24, 2026
Genome-wide copy number profiling enhances risk stratification in multiple myeloma by shallow whole-genome sequencingBaijun Fang, Zunmin Zhu, Yinyin Chang, et al.
Leukemia Research|October 6, 2017
Efficacy and safety of G-CSF, low-dose cytarabine and aclarubicin in combination with l-asparaginase, prednisone in the treatment of refractory or relapsed acute lymphoblastic leukemiaKeshu Zhou, Yongping Song, Yanli Zhang, et al.
Haematologica|July 4, 2007
Senescence-unrelated impediment of osteogenesis from Flk1+ bone marrow mesenchymal stem cells induced by total body irradiation and its contribution to long-term bone and hematopoietic injuryJie Ma, Mingxia Shi, Jing Li, et al.
Blood Cancer Journal|February 5, 2025
Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseasesXiangke Xin, Wenli Zhang, Zhen Li, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|April 30, 2020
Addition of low-dose decitabine to bortezomib and dexamethasone as second-line therapy in multiple myelomaNing Li, Lina Liu, Pu Xiang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 25, 2014
[Efficacy of adjusted BACOD regimen on the treatment of relapsed refractory diffuse large B cell lymphoma]Gege Gong, Jianwei Du, Lihua Dong, et al.
Annals of Palliative Medicine|January 12, 2022
Glutathione combined with mecobalamin in the treatment of chemotherapy-induced peripheral neuropathy in multiple myeloma: a retrospective clinical studyHao Huang, Min Zhao, Xiyang Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 24, 2019
Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinomaXiaojuan Shi, Xinfeng Chen, Baijun Fang, et al.
Blood Advances|December 12, 2025
Genome-wide copy number profiling enhances risk stratification in multiple myeloma by shallow whole-genome sequencingBaijun Fang, Zunmin Zhu, Yinyin Chang, et al.
Experimental Hematology|July 5, 2003
Hemangioblastic characteristics of fetal bone marrow-derived Flk1(+)CD31(-)CD34(-) cellsHong Guo, Baijun Fang, Lianming Liao, et al.
Blood Advances|February 24, 2026
Genome-wide copy number profiling enhances risk stratification in multiple myeloma by shallow whole-genome sequencingBaijun Fang, Zunmin Zhu, Yinyin Chang, et al.
Leukemia Research|October 6, 2017
Efficacy and safety of G-CSF, low-dose cytarabine and aclarubicin in combination with l-asparaginase, prednisone in the treatment of refractory or relapsed acute lymphoblastic leukemiaKeshu Zhou, Yongping Song, Yanli Zhang, et al.
Haematologica|July 4, 2007
Senescence-unrelated impediment of osteogenesis from Flk1+ bone marrow mesenchymal stem cells induced by total body irradiation and its contribution to long-term bone and hematopoietic injuryJie Ma, Mingxia Shi, Jing Li, et al.
Blood Cancer Journal|February 5, 2025
Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseasesXiangke Xin, Wenli Zhang, Zhen Li, et al.
Pageof 9